In this review, we discuss the challenges and strategies to effectively diagnose, treat, and manage mastocytosis associated with oncogenic KIT and other newly identified mutations in genes encoding epigenetic regulators and spliceosome machinery. This evidence concerns the gene KIT and mastocytosis.